Release Date: 05/10/10 09:21 Summary: ChemGenex Completes pre-NDA Meeting with U.S. FDA Price Sensitive: Yes Download Document 149.61KB Download
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress